<!DOCTYPE html>

<html lang="fa">
<meta content="text/html;charset=utf-8" http-equiv="content-type"/>
<head><title>Hemodialysis access-induced distal ischemia</title><link href="/d/css/bootstrap.min.css" rel="stylesheet"/><link href="/d/css/icofont.min.css" rel="stylesheet"/><link href="/d/css/classy-nav.min.css" rel="stylesheet"/><link href="/d/css/animate.css" rel="stylesheet"/><link href="/d/css/owl.carousel.css" rel="stylesheet"/><link href="/d/css/magnific-popup.css" rel="stylesheet"/><link href="/d/css/owl.theme.default.min.css" rel="stylesheet"/><link href="/d/css/style.css" rel="stylesheet"/><link href="/d/css/rtl_edited.css" rel="stylesheet"/><link href="/d/css/responsive.css" rel="stylesheet"/><link href="https://medilib.ir/uptodate_assets/main.css" rel="stylesheet">
<style>

#myUL {
  list-style-type: none;
  padding: 0;
  margin: 0;
}

#myUL li a {
  border: 1px solid #ddd;
  margin-top: -1px; /* Prevent double borders */
  background-color: #f6f6f6;
  padding: 12px;
  text-decoration: none;
  font-size: 16px;
  color: black;
  display: block
}

#myUL li a:hover:not(.header) {
  background-color: #eee;
}

#searchResult {

  list-style-type: none;
  padding: 0;
  padding-right: 20px;
}

#searchResult li a {
  border: .5px solid #ddd;
  margin-top: -1px; /* Prevent double borders */
  background-color: #79bc21;
  padding: 7px;
  text-decoration: none;
  font-size: 14px;
  color: white;
  display: block
}

#searchResult li a:hover:not(.header) {
  background-color: #222;
}


#txtHint   {
  position: absolute;
  text-shadow: none;
  width: 100%;
  margin-top: -15px;
  padding-right: 10px;

  filter: alpha(opacity=95);
  -moz-opacity: 0.95;
  opacity: 1;
  z-index: 200;
}
.countBubl {
  background:#eb0029;
  color:#fff;
  padding:5px;
  margin-top: 50%;

}
.uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > span:nth-child(1) > img:nth-child(2) {
 width: 55%;
 padding-left: 20px;
}
.uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > span:nth-child(1) > img:nth-child(3) {
 width: 20%;
}
 #Uptodate_image {
      width: 50%;
  }#uptodate-area {
      /*z-index: 99;*/
  }
#uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > div:nth-child(2) {
 margin-left: 10px;
 margin-bottom: 6%;
}
@media (max-width: @screen-xs) {
    .countBubl {
        font-size: 4px ;
    }
    #uptodate_version {
        font-size: 4px ;
    }
}

@media (max-width: @screen-sm) {
    .countBubl {
        font-size: 14px ;
    }
}
@media  all and(max-width: 820) {
    #Uptodate_image {
        width: 80% ;
    }#uptodate-area {
        z-index: 99;
    }
}@media  all and (min-width: 820) and(max-width: 88820){
    #Uptodate_image {
        width: 100% !important;
    }
    .countBubl {
        font-size: 4px ;
    }
}
div.col-md-3:nth-child(3) {
 margin-top: 6%;
}

div.col-md-3:nth-child(3) > img:nth-child(1) {
 width: 100%;
 margin-left: 11px;
}

</style>
<style media="screen" type="text/css">
  .goback {
    width: 200px;
    height: 40px;
    line-height: 40px;
    position: fixed;
    display: none;
    font-size: 15px;
    background: #71c0fa;
    z-index: 1000;
    text-align: center;
    color: #ffffff;
    -webkit-border-radius: 1px;
    -moz-border-radius: 1px;
    border-radius: 50px;
    bottom: 3.8%;
    right: 2%;
}
  .buyPackage {
  width: 100px;
  height: 100px;
  line-height: 40px;
  position: fixed;
  display: none;
  font-size: 10px;
  background: #fa759e;
  z-index: 1000;
  text-align: center;
  color: #ffffff;
  -webkit-border-radius: 1px;
  -moz-border-radius: 1px;
  border-radius: 10px;
  top: 150px;
  right: 2%;
  text-align: center;
}
.uptodate-area {
  /*background-image: url(../../assets/img/news-letter-bg.jpg);*/
  background-position: center center;
  background-size: cover;
  background-repeat: no-repeat;
    background-attachment: fixed;
  position: relative;
}
.uptodate-area::before {
  content: '';
  position: absolute;
  left: 0;
  padding-top: 100px;
  width: 100%;
}
#references{
  display: none;
}
</style>
<style>
section.sticky {
  position: sticky;
  top: 0;
  background-color: #fff !important;
  /*z-index: 100;*/
  /*padding-top: 80px;*/

}
.m4inb{
    border: solid !important;
  }

  .newsletter-area::before {
       background: unset !important;
  }
p {
    color: #555;
}
</style>

<meta content="" name="description"/>
<link href="/d/img/favicon.png" rel="icon" type="image/png"/>
</link></head>
<body>
<!-- Start Main Menu Area -->

<br/>
<br/>
<br/>
<br/>
<div class="container">
<div class="row">
</div>
</div>




<section class="teacher-area ptb-10">
<div class="container">
</div>

<section class="course-details-area ptb-60">
<div class="container">
<div class="uptodate2" style="padding:50px 0px 50px 0px;direction: ltr;text-align: left;">
<h1 style="text-align:center">Hemodialysis access-induced distal ischemia</h1>
<div class="utdArticleSection utdStyle" id="topicContent"><div id="topicTitle">Hemodialysis access-induced distal ischemia</div> <div class="authorSectionElem"><div class="authorsElementsLeft"><dl id="topicContributors"><dt><span> </span>Authors:</dt><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">Larry A Scher, MD, FACS</a></dd><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">Jeffrey E Indes, MD, FACS</a></dd><dt><span> </span>Section Editor:</dt><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">Ellen D Dillavou, MD</a></dd><dt><span> </span>Deputy Editor:</dt><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">Kathryn A Collins, MD, PhD, FACS</a></dd></dl></div><div class="authorsElementsRight"><div id="literatureReviewDate"><div class="litReviewSingleLine"><bdi><span class="emphasis">Literature review current through:</span> Jan 2024.</bdi></div><div class="litReviewSingleLine"><bdi><span class="emphasis">This topic last updated:</span> Oct 27, 2023.</bdi></div></div></div></div><div id="topicWhatsNewContainer"></div><div id="topicText"><p class="headingAnchor" id="H3484867129"><span class="h1">INTRODUCTION</span><span class="headingEndMark"> — </span>Ischemic complications of hemodialysis arteriovenous (AV) access are uncommon but can result in significant limb dysfunction or even limb loss. Ischemia can occur for a variety of reasons that almost always include decreased blood flow to the distal extremity resulting from blood flow through the AV fistula or AV graft. Preemptive strategies may mitigate the development of ischemic complications and should be considered in high-risk patients.</p><p>The incidence and timing for the development of hemodialysis access-induced distal ischemia (HAIDI), also called dialysis access steal syndrome (DASS), vary with the type and location of the access, and clinical symptoms can be graded from mild to severe. HAIDI is a more descriptive term of the multiple causes of access induced ischemia including DASS. In addition, HAIDI can present with high or low AV access volume flow, requiring individualized treatment algorithms. Ischemic monomelic neuropathy (IMN) is a variant that may lead to irreversible neurologic deficits and requires an aggressive management strategy. Treatment options for HAIDI include AV access ligation for severe ischemia, banding procedures to reduce flow in high-flow AV access, or procedures to modify access hemodynamics to improve distal blood flow [<a href="#rid1">1</a>]. </p><p>The clinical features, diagnosis, and treatment of HAIDI, including DASS and the variant IMN, are reviewed. Other complications related to hemodialysis AV access and general techniques for their creation are reviewed separately. (See  <a class="medical medical_review" href="/d/html/1917.html" rel="external">"Arteriovenous fistula creation for hemodialysis and its complications"</a> and  <a class="medical medical_review" href="/d/html/14023.html" rel="external">"Arteriovenous graft creation for hemodialysis and its complications"</a>.)</p><p class="headingAnchor" id="H89209018"><span class="h1">INCIDENCE, RISK FACTORS, AND PREVENTION</span><span class="headingEndMark"> — </span>Hemodialysis access-induced distal ischemia (HAIDI) manifesting as a symptomatic steal syndrome is reported to occur in 4 to 10 percent of patients undergoing vascular access for hemodialysis, with wide variations in the incidence reported in the literature [<a href="#rid2">2-5</a>]. In a large series of 4863 patients, the incidence of ischemia relative to type of arteriovenous (AV) access was reported as follows [<a href="#rid6">6</a>]: </p><p class="bulletIndent1"><span class="glyph">●</span>Snuffbox AV fistula: 0 percent</p><p class="bulletIndent1"><span class="glyph">●</span>Radiocephalic AV fistula: 0.3 percent</p><p class="bulletIndent1"><span class="glyph">●</span>Brachiocephalic AV fistula: 0.9 percent </p><p class="bulletIndent1"><span class="glyph">●</span>Brachiobasilic AV fistula: 3.7 percent</p><p class="bulletIndent1"><span class="glyph">●</span>Brachiocephalic/basilic AV fistula: 5.2 percent</p><p class="bulletIndent1"><span class="glyph">●</span>Polytetrafluoroethylene AV graft: 2.2 percent </p><p></p><p>In a separate review of 602 patients from the Hemodialysis Fistula Maturation Study, the overall incidence of dialysis access steal syndrome (DASS) was 7 percent with 4 percent of patients experiencing symptoms sufficiently severe to warrant surgical intervention [<a href="#rid7">7</a>].</p><p class="headingAnchor" id="H2013484299"><span class="h2">Risk factors</span><span class="headingEndMark"> — </span>Identifying patients who have risk factors for developing HAIDI is important so that preemptive measures can be considered to reduce the risk of ischemic complications [<a href="#rid8">8</a>]. (See <a class="local">'Strategies for prevention'</a> below.)</p><p>In a review of 325 upper extremity procedures in which the overall incidence of steal was 6.2 percent, univariate analysis identified brachial artery inflow, diabetes, female sex, coronary heart disease, cerebrovascular disease, and age over 60 as risk factors for the development of steal [<a href="#rid4">4</a>]. Other risk factors identified in separate reviews include hypertension, capacitant outflow veins, and tobacco use [<a href="#rid7">7-9</a>].</p><p>Strategies to avoid brachial artery inflow for hemodialysis AV access should be considered, but efforts to predict the development of HAIDI in individual patients have been unsuccessful. A digital brachial index less than 0.6 identifies patients at risk for steal syndrome, but intraoperative measurement of digital brachial index cannot be used to reliably predict who will develop ischemia [<a href="#rid10">10</a>]. Similarly, preoperative finger pressures are lower in patients who develop ischemia, but there is no threshold pressure below which steal is inevitable [<a href="#rid11">11</a>]. </p><p>Atherosclerotic vascular disease can be a risk factor for steal but is also a risk factor for digital gangrene. In a small review of 23 patients with finger gangrene, 45 percent had a functional ipsilateral AV fistula [<a href="#rid12">12</a>]. Patients were mostly young and had diabetes, and arteriography uniformly demonstrated diffuse atherosclerosis involving the radial, ulnar, palmar, and digital arteries precluding attempts at distal arterial bypass. Noninvasive testing with AV fistula compression failed to improve digital blood flow. The authors concluded that finger gangrene in this younger patient population was the result of distal atherosclerosis and rarely primarily related to the hemodialysis AV access.</p><p class="headingAnchor" id="H2966618446"><span class="h2">Strategies for prevention</span><span class="headingEndMark"> — </span>Although it remains impossible to predict the development of HAIDI in individual patients, specific strategies can be implemented to minimize the risk. These include preemptive identification of arterial disease and avoiding using the brachial artery as an inflow vessel.</p><p class="headingAnchor" id="H837416591"><span class="h3">Identifying correctable arterial lesions</span><span class="headingEndMark"> — </span>Although proximal arterial disease as a cause of HAIDI is uncommon, it can be easily identified and treated to reduce the development of steal or to successfully treat symptomatic steal after AV access placement [<a href="#rid13">13</a>]. (See  <a class="medical medical_review" href="/d/html/110008.html" rel="external">"Patient evaluation prior to placement of hemodialysis arteriovenous access", section on 'Arterial evaluation'</a>.)</p><p>Preoperative noninvasive testing should include, at a minimum, a full upper extremity pulse examination, bilateral upper extremity blood pressures, and full duplex ultrasound mapping of bilateral upper extremity arteries and veins. A blood pressure differential of greater than 20 mmHg, an asymmetric pulse exam, unexpectedly weak pulses at any level in the arm, or findings on duplex ultrasound of significant arterial stenosis proximal to the proposed AV access mandate additional vascular imaging. In addition, a modified Allen's test can be performed to evaluate the status of the palmar arch, although the significance of a positive or negative test result in the planning of hemodialysis AV access is controversial. </p><p>Although preoperative photoplethysmography (PPG) is not routinely performed, it can be helpful in the evaluation of symptomatic patients with arterial insufficiency and helps guide AV access placement to avoid ischemic complications. </p><p class="headingAnchor" id="H1181083426"><span class="h3">Avoiding brachial artery inflow</span><span class="headingEndMark"> — </span>Perhaps the most important strategy available to reduce the risk of ischemia is to minimize the use of the brachial artery for inflow for hemodialysis AV access. Distal AV fistulas created at the wrist using radial artery inflow have an extremely low incidence of HAIDI. Unfortunately, unfavorable venous anatomy and circumferential radial artery calcification often seen in patients with diabetes may preclude the creation of distal radiocephalic AV fistula. An alternative method uses the proximal radial artery  (<a class="graphic graphic_figure graphicRef122921" href="/d/graphic/122921.html" rel="external">figure 1</a>), rather than the brachial artery for inflow when more distal arterial inflow is not feasible [<a href="#rid14">14</a>]. The brachial artery bifurcation and proximal radial artery can be easily identified by preoperative duplex ultrasound, and AV fistulas can be performed in the cephalic, basilic, or median antecubital vein with excellent functional patency and a low risk of ischemia. In a series of 1396 proximal radial artery AV fistulas, DASS requiring intervention occurred in only 39 (2.8 percent) [<a href="#rid15">15</a>]. </p><p>Another option that has been proposed is the primary use of proximal arterial inflow to possibly mitigate the risk of set [<a href="#rid14">14</a>]. This strategy of proximalization of arterial inflow (PAI) has been successfully used to treat DASS when it occurs, and strategies to preemptively create autogenous AV access using axillary artery inflow have been successful for preventing DASS in selected high-risk patients [<a href="#rid16">16</a>]. (See <a class="local">'Proximalization of arterial inflow'</a> below.)</p><p class="headingAnchor" id="H2551178926"><span class="h3">Limiting proximal arterial inflow</span><span class="headingEndMark"> — </span>If arterial inflow must originate from arteries proximal to the radial artery, in particular proximal to the brachial bifurcation, limiting the inflow may provide an advantage. </p><p>Limiting the length of the arteriotomy to a maximum of 4 to 6 mm may be particularly important in patients with diabetes or peripheral artery disease. In addition, use of continuous suture may prevent future increases in the anastomotic surface area and prevent late development of DASS [<a href="#rid17">17</a>]. Whether the configuration of the anastomosis impacts the incidence of DASS was evaluated in a meta-analysis that included 301 AV fistulas [<a href="#rid18">18</a>]. The risk of developing DASS was significantly lower for an end-to-side anastomosis compared with side-to-side anastomosis with no effect on maturation or patency.</p><p>When an AV graft is selected for hemodialysis AV access, tapered polytetrafluoroethylene grafts for hemodialysis AV access have the theoretic advantage of limiting volume flow and reducing the incidence of DASS compared with straight 6 mm AV grafts. However, randomized trials have produced equivocal results regarding the value of tapered AV grafts. One trial suggested that AV graft flow and rates of thrombosis and ischemia were similar for straight 6 mm compared with 4 to 7 mm tapered AV grafts placed in a forearm loop configuration [<a href="#rid19">19</a>]. Another trial randomly assigned patients without diabetes to 6 mm straight AV grafts or 6 to 8 mm tapered AV grafts in a brachial axillary position and reported improved primary and primary assisted patency rates for the tapered AV grafts but similar secondary patency [<a href="#rid20">20</a>]. The complication rate was 0.45 episodes per graft-year for 6 mm AV grafts, and 0.19 episodes per graft-year for the 6 to 8 mm AV grafts. Although five patients in the 6 mm group and seven patients in the tapered group had transient pallor or coolness of the hand, no patient in either group developed clinical steal requiring intervention. In a later review of 3608 upper extremity AV grafts reported from the Vascular Quality Initiative, patency rates and the incidence of DASS were no different for tapered compared with straight AV grafts [<a href="#rid21">21</a>]. Regardless of the equivocal clinical evidence supporting their use, tapered AV grafts continue to be widely used in clinical practice. </p><p class="headingAnchor" id="H2868087148"><span class="h3">Limiting venous outflow</span><span class="headingEndMark"> — </span>The antecubital fossa has a wide range of options for venous outflow. Limiting outflow to superficial and accessible veins can further reduce the risk of ischemia and improve AV fistula maturation rates. The importance of ligating the perforating venous branch, which is consistently present and joins the brachial vein, has been emphasized [<a href="#rid22">22</a>]. This branch can be used for the AV fistula anastomosis but otherwise should be ligated to improve superficial venous flow and AV fistula maturation and also reduce the risk of steal. Significantly improved radial artery pressure has been demonstrated after ligation of the deep perforating vein, suggesting that a considerable amount of flow from the AV fistula was diverted into the deep venous system [<a href="#rid22">22</a>]. In addition, careful attention to the antecubital venous anatomy will maximize functional patency of the AV fistula and minimize ischemic complications. AV fistula outflow into both the basilic and cephalic veins may be advantageous in situations where marginal veins are used and maturation is unpredictable. However, there may be also a potential disadvantage to preserving unnecessary venous collaterals or outflow veins in the risk of developing DASS [<a href="#rid23">23</a>]. How these factors will be influenced by new percutaneous AV fistula creation techniques, which often result in deep and superficial venous outflow, remains to be seen.</p><p class="headingAnchor" id="H3858375924"><span class="h1">CLINICAL MANIFESTATIONS</span><span class="headingEndMark"> — </span>After the creation of an arteriovenous (AV) fistula, it is critical that every patient have verbal and written instructions describing the symptoms associated with hemodialysis access-induced distal ischemia (HAIDI) including dialysis access steal syndrome (DASS) and ischemic monomelic neuropathy (IMN). The patient should be instructed to contact their surgeon or another health care provider immediately if the symptoms described below occur since permanent injury (eg, nerve damage) can result from delays in care.</p><p class="headingAnchor" id="H3689081213"><span class="h2">Dialysis access steal syndrome</span><span class="headingEndMark"> — </span>Presenting symptoms and signs of DASS are those of upper extremity ischemia such as hand pain, coldness, diminished sensation or motor function, cyanosis or pallor of the digits, and diminished or absent pulses. Less severe symptoms and signs, such as paresthesias and a sense of coolness with retained pulses, are more common. Severe ischemic symptoms, characterized by loss of sensation or weakness, may be more common among patients with diabetes and in those of advanced age [<a href="#rid24">24,25</a>]. Symptoms often worsen during hemodialysis sessions. Symptoms may improve with compression of the AV access. (See <a class="local">'Diagnosis'</a> below and  <a class="medical medical_review" href="/d/html/118660.html" rel="external">"Overview of upper extremity ischemia"</a>.)</p><p>In a review that included 21 studies reporting on surgically or percutaneously treated patients with DASS, symptoms were classified as "acute" (&lt;24 hours after AV access construction), "subacute" (within one month), or "chronic" (after one month) [<a href="#rid26">26</a>]. The occurrence of acute DASS correlated strongly (88 percent) with nonautogenous AV access (ie, AV graft), and chronic DASS was predominantly (91 percent) observed following autogenous AV access (ie, AV fistula) usually based on brachial artery inflow. </p><p class="headingAnchor" id="H1314072923"><span class="h2">Ischemic monomelic neuropathy</span><span class="headingEndMark"> — </span>IMN is a rare variant of HAIDI that likely is within the spectrum of ischemic steal, but it has distinct characteristics from the typical presentation [<a href="#rid27">27</a>]. IMN is caused by focal nerve ischemia and generally results from sudden diversion of the blood supply away from the nerves of the forearm and hand. The condition is uncommon, and the true incidence is unknown, but IMN almost universally occurs with brachial artery-based AV access procedures and predominates in females and patients with diabetes. Dysfunction of multiple upper extremity peripheral nerves occurs [<a href="#rid28">28</a>]. </p><p>Symptom onset is usually immediately after AV access placement, and neurologic symptoms predominate, often in the absence of tissue ischemia of the hand. IMN presents as diffuse sensory and motor deficits in the radial, ulnar, or median nerve distributions. Presenting symptoms include pain, paresthesias, and numbness in the hand. Significant motor dysfunction is also present, and deficits include poor wrist extension, poor function of the intrinsic hand musculature, and poor thumb opposition. These deficits can progress to a typical claw hand deformity  (<a class="graphic graphic_picture graphicRef122922" href="/d/graphic/122922.html" rel="external">picture 1</a>). Typically, the hand is warm, capillary refill is preserved, and a palpable radial or ulnar pulse or audible Doppler signal is present. The absence of tissue ischemia is in distinct contrast to the clinical presentation of typical DASS.</p><p class="headingAnchor" id="H274451516"><span class="h1">CLINICAL STAGING</span><span class="headingEndMark"> — </span>Multiple authors have attempted to grade or stage the severity of hemodialysis access-induced distal ischemia (HAIDI) [<a href="#rid29">29,30</a>]. Staging is generally based on the clinical presentation and is correlated with the need for intervention. An individualized approach to treatment based on clinical staging is presented below. (See <a class="local">'Individualized approach to HAIDI'</a> below.)</p><p>An early classification described ischemia as mild (stage 1), moderate (stage 2), or severe (stage 3) [<a href="#rid30">30</a>]. A later classification provided a more detailed four-stage classification, which is shown in the table  (<a class="graphic graphic_table graphicRef123002" href="/d/graphic/123002.html" rel="external">table 1</a>) [<a href="#rid29">29</a>]. </p><p class="headingAnchor" id="H919984454"><span class="h1">DIAGNOSIS</span><span class="headingEndMark"> — </span>The diagnosis is predominantly clinical based on history and physical examination findings of upper extremity ischemia in a patient with an arteriovenous (AV) access. Physical examination can confirm a diagnosis of vascular steal by manually compressing the AV access and noting an improvement in the patient's symptoms. However, physical examination alone may not be accurate in identifying the anatomic cause of the vascular steal [<a href="#rid31">31</a>]. Thus, among patients presenting with symptoms of extremity ischemia, there is a low threshold to obtain noninvasive vascular evaluation. The diagnosis can be confirmed using noninvasive vascular testing. Physiologic tests such as digital waveforms and pressures, with and without AV fistula compression, are sensitive for a diagnosis of steal. Duplex ultrasound may identify the presence of arterial stenosis and/or flow reversal and can quantify flow [<a href="#rid32">32-34</a>]. For patients suspected of having a proximal lesion, and for whom treatment is being considered, upper extremity arteriography may be appropriate. (See <a class="local">'Noninvasive vascular studies'</a> below.) </p><p class="headingAnchor" id="H3379872107"><span class="h2">Differentiating IMN from DASS</span><span class="headingEndMark"> — </span>Recognition of ischemic monomelic neuropathy (IMN) may be problematic because of its infrequent occurrence and absence of significant tissue ischemia in the involved extremity. The presence of severe hand pain but absence of significant tissue ischemia with the presence of a radial artery pulse or Doppler signal and preserved digital blood flow differentiates IMN from dialysis access steal syndrome (DASS) [<a href="#rid35">35</a>]. Electromyography performed on patients with IMN may demonstrate signs of acute denervation. </p><p>The following features help distinguish IMN from DASS [<a href="#rid25">25</a>]: </p><p class="bulletIndent1"><span class="glyph">●</span>Immediate onset for IMN versus insidious for DASS.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Females and patient with diabetes predominate for IMN, whereas the sex distribution is variable for DASS.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>For IMN, brachial-based AV access is predominantly affected. For DASS, AV access at any level can be affected.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Only nerve tissue is affected with IMN, and the level of nerve ischemia is severe  (<a class="graphic graphic_picture graphicRef122922" href="/d/graphic/122922.html" rel="external">picture 1</a>). For DASS, tissue ischemia can range from mild to severe and affects the skin more than the muscles and more than the nerves. </p><p></p><p class="bulletIndent1"><span class="glyph">●</span>The radial pulse should be present in IMN and is weak or absent with DASS. The digital pressures follow this pattern (ie, normal or slightly decreased with IMN, but markedly decreased with DASS).</p><p></p><p class="headingAnchor" id="H3479547846"><span class="h2">Differential diagnosis</span><span class="headingEndMark"> — </span>The differential diagnosis includes any of the other causes of upper extremity ischemia, including, but not limited to, atherosclerotic disease, embolism, traumatic (including iatrogenic) injury, arterial dissection, and arteritis. (See  <a class="medical medical_review" href="/d/html/118660.html" rel="external">"Overview of upper extremity ischemia", section on 'Incidence and etiologies'</a>.)</p><p>The differential diagnosis of extremity hand pain or hand dysfunction temporally related to surgery for the creation of the hemodialysis AV access includes incisional pain, surgical site infection, hematoma, complications of anesthesia, peripheral nerve compression, and carpal tunnel syndrome.</p><p class="headingAnchor" id="H2004242295"><span class="h2">Noninvasive vascular studies</span><span class="headingEndMark"> — </span>To confirm the diagnosis and assess the severity of ischemia, noninvasive vascular testing using digital photoplethysmography tracings (ie, PPGs) and pressure measurements, and duplex ultrasound to assess flow direction and volume flow, are useful tools. </p><p class="headingAnchor" id="H3669029169"><span class="h3">Digital studies with arteriovenous access compression</span><span class="headingEndMark"> — </span>Evaluation of digital pressure measurement as well as the amplitude of PPGs at rest and with AV access compression  (<a class="graphic graphic_waveform graphicRef122926" href="/d/graphic/122926.html" rel="external">waveform 1</a>) can help confirm a diagnosis of hemodialysis access-induced distal ischemia (HAIDI). In a study that measured arterial pressure in the third finger ipsilateral to the AV access in 40 patients with clinical ischemia and 25 patients without ischemia, the mean digital pressure was significantly lower in patients with HAIDI (30 versus 102 mmHg), as was the mean digital brachial index (DBI) value (0.3 versus 0.8) [<a href="#rid36">36</a>]. The change in digital pressure with AV access compression was also significantly lower in patients with HAIDI. The authors established that a digital pressure &lt;60 mmHg or a DBI &lt;0.4 in a patient with an AV access was highly associated with hand ischemia. In addition to aiding diagnosis, a lack of improvement in hemodynamics with compression of the AV fistula may help to identify patients who will <strong>not</strong> benefit from an intervention that specifically targets the existing AV access.</p><p class="headingAnchor" id="H1174842824"><span class="h3">Duplex ultrasound</span><span class="headingEndMark"> — </span>Duplex ultrasound is another important tool in the evaluation of HAIDI. However, while identification of flow reversal in the artery distal to the AV access is helpful in the diagnosis, it does not necessarily correlate with clinical symptoms or dictate the need for intervention. </p><p class="headingAnchor" id="H1749612294"><span class="h4">Quantifying arteriovenous access flow</span><span class="headingEndMark"> — </span>Measurement of volume flow is not helpful for establishing a diagnosis of HAIDI, but it is critical in planning treatment in symptomatic patients. (See <a class="local">'Individualized approach to HAIDI'</a> below and <a class="local">'High-flow arteriovenous fistulas'</a> below.)</p><p>Measurement of volume flow (expressed in mL/min) in the AV access can be accomplished using ultrasound measurements of vessel diameter combined with Doppler-derived velocity determinations [<a href="#rid37">37</a>]. Alternatively, one of the dilution methods can be used. (See  <a class="medical medical_review" href="/d/html/1970.html" rel="external">"Clinical monitoring and surveillance of the mature hemodialysis arteriovenous fistula", section on 'Intra-access flow rate'</a> and  <a class="medical medical_review" href="/d/html/1965.html" rel="external">"Clinical monitoring and surveillance of hemodialysis arteriovenous grafts to prevent thrombosis", section on 'Intra-access blood flow monitoring'</a>.)</p><p>AV access flow can be arbitrarily defined as low (&lt;600 mL/min), normal (600 to 1500 mL/min), and high (&gt;1500 mL/min) [<a href="#rid38">38</a>]. Ideal AV access flow is the minimal flow that is adequate to prevent thrombosis but provides adequate hemodialysis. Complications such as HAIDI and aneurysmal AV fistula degeneration  (<a class="graphic graphic_picture graphicRef117563" href="/d/graphic/117563.html" rel="external">picture 2</a>) can occur with high- or low- flow AV access. Similarly, cardiac dysfunction, congestive heart failure, and pulmonary hypertension can occur with low- or normal-flow AV access but can be exacerbated by high-flow fistulas, which can significantly increase cardiac output. (See <a class="local">'High-flow arteriovenous fistulas'</a> below.)</p><p class="headingAnchor" id="H1793172065"><span class="h1">APPROACH TO MANAGEMENT</span></p><p class="headingAnchor" id="H1009726556"><span class="h2">Individualized approach to HAIDI</span><span class="headingEndMark"> — </span>Treatment of hemodialysis access-induced distal ischemia (HAIDI) should be individualized and is based upon the clinical stage and severity of ischemia, type and location of arteriovenous (AV) access, and its volume flow [<a href="#rid5">5,24,29,39</a>]. </p><p>The clinical features and staging are presented above  (<a class="graphic graphic_table graphicRef123002" href="/d/graphic/123002.html" rel="external">table 1</a>). (See <a class="local">'Clinical staging'</a> above.)</p><p>The treatment of HAIDI based on staging is as follows  (<a class="graphic graphic_algorithm graphicRef122924" href="/d/graphic/122924.html" rel="external">algorithm 1</a>): </p><p class="bulletIndent1"><span class="glyph">●</span>Stage I/IIa – Does not require intervention and should be managed conservatively with close observation of symptoms. </p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Stage IIb/III/IVa requires intervention, the nature of which is based on AV access volume flow. (See <a class="local">'Treatment options'</a> below.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Stage IVb – The limb is managed expectantly; amputation is frequently necessary. (See  <a class="medical medical_review" href="/d/html/15224.html" rel="external">"Upper extremity amputation", section on 'Digit and thumb amputation'</a>.)</p><p></p><p>For patients who do not require intervention but have mild symptoms, medications should be optimized to stabilize blood pressure and prevent hypotension (particularly important while on hemodialysis), and a warming glove can be used. Vigilant follow-up and patient instruction to avoid injury to the hand and to call for worsening symptoms are essential. </p><p>AV access ligation would effectively reverse ischemic symptoms in most cases, but preservation of the AV access, if possible, should be an equally important goal. The importance of determining AV access volume flow has been emphasized; treatment differs for high-flow versus normal- or low-flow dialysis access steal syndrome (DASS) [<a href="#rid29">29</a>]. Using an algorithm, such as one based on AV access flow  (<a class="graphic graphic_algorithm graphicRef122924" href="/d/graphic/122924.html" rel="external">algorithm 1</a>), is helpful for determining the best treatment in these challenging patients.<strong> </strong>(See <a class="local">'Quantifying arteriovenous access flow'</a> above.)</p><p>Flow-dependent treatment can be summarized as follows:</p><p class="bulletIndent1"><span class="glyph">●</span>A high-flow AV access (&gt;1500 mL/min) may require only flow reduction. (See <a class="local">'Precision banding'</a> below.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>A low- or normal-flow AV access (≤1500 mL/min) will require a revascularization procedure to alter flow hemodynamics of the AV access to improve distal perfusion while maintaining AV access function. (See <a class="local">'Revascularization procedures'</a> below.)</p><p></p><p class="headingAnchor" id="H2114398059"><span class="h2">Arteriovenous access ligation for IMN</span><span class="headingEndMark"> — </span>We agree with the National Kidney Foundation Kidney Disease Outcomes Quality Initiative (KDOQI) Clinical Practice Guideline for Vascular Access: 2019 Update, and the Society for Vascular Surgery Clinical Practice Guidelines for the Surgical Placement and Maintenance of Arteriovenous Hemodialysis Access, that recommend immediate AV access closure when ischemic monomelic neuropathy (IMN) is diagnosed [<a href="#rid24">24</a>]. This results in loss of AV access and the need to search for alternative sites with the same potential risks. (See <a class="local">'Arteriovenous access ligation'</a> below.)</p><p>These recommendations are based on limited data as large series of patients with IMN are lacking in the literature. Until more effective strategies can be developed to prevent or manage IMN, it seems reasonable to recommend AV access closure in patients with available alternative AV access sites. Despite these recommendations, recovery from this condition is at best unpredictable. Even with timely diagnosis and appropriate intervention, patients may have persistent and significant clinical deficits [<a href="#rid27">27,35,40</a>]. In separate reviews, the majority of patients with IMN were treated with ligation of the AV access, but the results of treatment were variable, with the majority of patients demonstrating only partial clinical recovery [<a href="#rid35">35,40</a>]. The level of improvement after treatment may be related to the duration of ischemia.</p><p class="headingAnchor" id="H2636288368"><span class="h2">High-flow arteriovenous fistulas</span><span class="headingEndMark"> — </span>A high-flow AV fistula is defined as one that has a volume flow &gt;1500 mL/min [<a href="#rid38">38</a>]. High-flow hemodialysis AV access can produce symptoms of DASS but can also be asymptomatic. (See  <a class="medical medical_review" href="/d/html/15074.html" rel="external">"High-flow hemodialysis arteriovenous access"</a>.)</p><p>High-flow AV fistulas also have the potential to cause numerous AV access-related and cardiovascular complications. These complications are listed below and reviewed separately. </p><p class="bulletIndent1"><span class="glyph">●</span>Aneurysmal enlargement of the AV access (see  <a class="medical medical_review" href="/d/html/1917.html" rel="external">"Arteriovenous fistula creation for hemodialysis and its complications", section on 'Aneurysm/pseudoaneurysm/megafistula'</a>)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Accelerated central venous stenosis (see  <a class="medical medical_review" href="/d/html/1913.html" rel="external">"Central vein obstruction associated with upper extremity hemodialysis access"</a>)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Pulmonary hypertension (see  <a class="medical medical_review" href="/d/html/112442.html" rel="external">"Pulmonary hypertension in patients with end-stage kidney disease"</a>)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Cardiac overload and cardiopulmonary recirculation (see  <a class="medical medical_review" href="/d/html/1958.html" rel="external">"Evaluation and management of heart failure caused by hemodialysis arteriovenous access"</a>)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Functional outflow obstruction (eg, cephalic arch stenosis) (see  <a class="medical medical_review" href="/d/html/1957.html" rel="external">"Failure of the mature hemodialysis arteriovenous fistula", section on 'Stenotic vascular lesions'</a>)</p><p></p><p>Inflow/outflow mismatch can occur in the presence of cephalic arch stenosis or central venous occlusion and can lead to significant arm swelling and the development of chest wall collateral veins. When central venous occlusion persists in spite of attempted interventions, flow reduction in the AV fistula may improve arm swelling. In one small review, the Minimally Invasive Limited Ligation Endoluminal-assisted Revision (MILLER) banding procedure reduced AV access flow in 22 patients with central venous occlusion with improvement or resolution of swelling in all cases [<a href="#rid41">41</a>]. (See <a class="local">'Precision banding'</a> below.)</p><p>Cardiac decompensation is a significant concern in the end-stage kidney disease population, particularly with the potential of the AV access to produce structural and functional cardiac changes as a result of the increased cardiac output [<a href="#rid42">42</a>]. High-output cardiac failure is a combination of clinical findings of systemic venous or pulmonary congestion and a resting cardiac output of greater than 8 L/min. Management focuses on medical treatment to reduce volume excess and reduction of AV access flow. Flow reduction in patients with high-flow AV fistulas improves cardiovascular performance and decreases need for hospitalization for acute heart failure [<a href="#rid43">43</a>]. In patients with cardiac overload and steal symptoms, flow reduction can be accomplished by minimally invasive techniques such as the MILLER banding technique or by open surgical plication or banding of the AV access with excellent outcomes [<a href="#rid44">44</a>]. Other techniques (eg, proximal radial artery ligation [PRAL], revision using distal inflow [RUDI]) for AV access flow reduction have also been used for cardiac failure [<a href="#rid45">45</a>]. AV access ligation remains an option if severe heart failure persists after efforts at flow reduction have failed. Controversy exists over the decision to ligate a functioning AV access after successful renal transplant to prevent long-term cardiac decompensation [<a href="#rid43">43</a>]. (See <a class="local">'Precision banding'</a> below and <a class="local">'Revascularization procedures'</a> below.)</p><p class="headingAnchor" id="H134452003"><span class="h1">TREATMENT OPTIONS</span><span class="headingEndMark"> — </span>Severe or persistent ischemic symptoms warrant treatment to prevent the development of permanent injury  (<a class="graphic graphic_algorithm graphicRef122924" href="/d/graphic/122924.html" rel="external">algorithm 1</a>). (See <a class="local">'Individualized approach to HAIDI'</a> above.)</p><p class="bulletIndent1"><span class="glyph">●</span>For patients with inflow arterial stenosis or progressive arterial occlusive disease in the extremity proximal to the arteriovenous (AV) anastomosis, percutaneous catheter-based arterial intervention may benefit the patient. (See <a class="local">'Treatment of inflow stenosis'</a> below.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>For patients with a distal radial AV fistula, occlusion of the artery distal to the anastomosis eliminates reversal of flow without jeopardizing the extremity or the AV access provided the ulnar artery is patent. (See <a class="local">'Distal artery occlusion'</a> below.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>For patients with a high-flow AV fistula, flow reduction using precision banding (eg, open or minimally invasive limited ligation endoluminal-assisted revision [MILLER] procedure) can be performed. (See <a class="local">'Precision banding'</a> below.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>For patients in whom preservation of the AV fistula is a high priority, revascularization procedures specifically designed to improve distal flow  (<a class="graphic graphic_figure graphicRef76970" href="/d/graphic/76970.html" rel="external">figure 2</a>) include the distal revascularization interval ligation (DRIL) procedure, proximalization of arterial inflow (PAI), and revision using distal inflow (RUDI). (See <a class="local">'Revascularization procedures'</a> below.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>For patients with ischemic symptoms that are very severe or in whom revascularization is not possible (eg, ischemic monomelic neuropathy [IMN]), the AV access will require ligation. (See <a class="local">'Arteriovenous access ligation'</a> below.)</p><p></p><p>The theoretical effects of several potential AV access modifications used to mitigate ischemia have been analyzed [<a href="#rid46">46</a>]. An extended axillobrachial bypass (distal revascularization part of the DRIL) increased forearm blood flow by a factor of 1.2 to 12.1, and ligating the intervening vessel (conversion to DRIL) increased the forearm flow by an additional factor of only 1.4 to 1.9. Moving the arterial anastomosis to a more proximal site increased forearm blood flow by increasing pressure at the split point between the distal circulation and the hemodialysis AV access and also initiated collateral flow at a higher point in the arm, which was advantageous for preventing or treating ischemic symptoms in the hand. </p><p>It is important to note the medicolegal implications of hemodialysis access-induced distal ischemia (HAIDI) including dialysis access steal syndrome (DASS) and IMN. Clinical decision making may be challenging, and appropriate documentation of treatment options and potential consequences is important. (See  <a class="medical medical_review" href="/d/html/112638.html" rel="external">"Malpractice risk associated with surgical procedures"</a>.)</p><p class="headingAnchor" id="H249244115"><span class="h2">Treatment of inflow stenosis</span><span class="headingEndMark"> — </span>Although proximal arterial disease as a cause of HAIDI is uncommon, it can be identified by simple techniques such as pulse examination, differential blood pressure measurements, duplex ultrasound, or angiography. Treatment of the inflow stenosis in patients with ischemia may be curative or serve as an adjunct to other treatments.</p><p>In a review of 52 patients with severe HAIDI requiring intervention, significant subclavian or brachial artery stenosis was found in nearly one third of the patients [<a href="#rid13">13</a>]. A review of upper extremity endovascular interventions for symptomatic HAIDI reported a high success rate for interventions performed for atherosclerotic disease [<a href="#rid47">47</a>]. Clinical outcomes were worse for patients with disease below the elbow. Such findings underscore the importance of preoperative vascular assessment. (See <a class="local">'Identifying correctable arterial lesions'</a> above and  <a class="medical medical_review" href="/d/html/110008.html" rel="external">"Patient evaluation prior to placement of hemodialysis arteriovenous access", section on 'Arterial evaluation'</a>.)</p><p class="headingAnchor" id="H3735722880"><span class="h2">Distal artery occlusion</span><span class="headingEndMark"> — </span>Although HAIDI is rare with radiocephalic AV fistulas, occlusion of the distal artery, which eliminates flow reversal, is an option unique to this site. Distal radial artery occlusion can be accomplished by embolization or with open surgical ligation [<a href="#rid48">48</a>].</p><p>Occlusion of the distal artery eliminates reversal of flow without jeopardizing the extremity or the AV access provided the ulnar artery is patent. Duplex ultrasound confirmation of flow reversal in the distal radial artery and ulnar artery patency is critical before this procedure is undertaken. In addition, improvement in digital waveforms should be demonstrated by compressing the AV access or the radial artery distal to the AV fistula. </p><p class="headingAnchor" id="H3922350130"><span class="h2">Precision banding</span><span class="headingEndMark"> — </span>For high-flow AV fistulas, banding may be effective for treating DASS and also for reducing potentially life-threatening cardiopulmonary complications and other problems associated with pathologic increases in cardiac output. (See <a class="local">'High-flow arteriovenous fistulas'</a> above.)</p><p>Banding can be accomplished using a variety of catheter-based or open surgical techniques. Precision banding implies that the procedure is done in conjunction with accurate measurements of the degree of flow reduction [<a href="#rid49">49</a>]. </p><p>Open surgical banding can be performed with plication, interposition of a narrow segment of conduit, or placement of a cuff or suture over an intraluminal balloon or dilator to achieve precise results [<a href="#rid50">50</a>]. A minimally invasive method for performing precision banding, the Minimally Invasive Limited Ligation Endoluminal-assisted Revision (MILLER) procedure, has reported excellent results [<a href="#rid44">44,51</a>]. Another technique has described banding between puncture sites in low-flow AV fistulas to maintain a pressure gradient between the arterial and venous puncture sites that would not be possible with traditional banding at the arterial anastomosis [<a href="#rid52">52</a>]. Novel endovascular approaches to flow reduction using stent-grafts have also been proposed [<a href="#rid53">53,54</a>].</p><p>Outcomes of banding can be assessed by measuring digital pressures or digital brachial index or with photoplethysmography, pulse volume recording (PVR) waveforms, or duplex ultrasound-derived volume flow measurements. In a small study of five patients with DASS, resolution of ischemic symptoms with AV access banding occurred in all patients with intraoperative increase of 5 mm in the PVR waveforms [<a href="#rid55">55</a>]. In addition, intraoperative measurement of volume flow after banding can confirm reduction of high flow. In a one-year follow-up study after surgical banding of high-flow AV accesses, 52 percent of patients developed recurrent high flow (&gt;2 L/min) [<a href="#rid56">56</a>]. Risk factors for recurrent high flow in banded brachial artery-based AV accesses were immediate postbanding AV access flow of &gt;1 L/min and young age (&lt;45 years).</p><p class="headingAnchor" id="H3660945884"><span class="h2">Revascularization procedures</span><span class="headingEndMark"> — </span>For low- or normal-flow AV access associated with HAIDI, revascularization options include DRIL or PAI  (<a class="graphic graphic_figure graphicRef76970" href="/d/graphic/76970.html" rel="external">figure 2</a>). DRIL is an effective technique for the treatment of vascular access-induced ischemia with adequate long-term outcomes. For high-flow AV fistulas, RUDI can be used. RUDI revises high-flow fistulas, and effectively changes the flow dynamics in the arm after the procedure [<a href="#rid57">57</a>]. </p><p>The arterial ligation required in the DRIL procedure theoretically puts the extremity at risk if the bypass fails, whereas both the RUDI and PAI procedures, which do not include arterial ligation, put the AV access rather than the extremity at risk in case of bypass failure.</p><p>There are few direct comparisons between the various procedures. </p><p class="bulletIndent1"><span class="glyph">●</span>One retrospective review compared DRIL with RUDI for the treatment of ischemic symptoms in 58 patients [<a href="#rid58">58</a>]. The main indication for intervention was tissue loss, which occurred in 61 percent; the remainder had ischemic rest pain. There were no significant differences in primary patency, cumulative secondary patency, survival at one and three years, or resolution or improvement in pain/healing of ischemic ulcers or amputations. </p><p></p><p class="bulletIndent1"><span class="glyph">●</span>A large retrospective series looked at 22 studies (459 individuals) who were underwent DRIL [<a href="#rid5">5</a>]. The time to ischemia was 196 days (interquartile range 30 to 600 days). Ischemia grade 3 and 4 was the most common presentation occurring in 52 percent. The overall success (grades 1 to 4) was 81 percent (95% CI, 80.9-82.5) during a mean follow-up of 22.2 months. The conduit of choice was the great saphenous vein (65 percent), and bypass thrombosis was highest in the polytetrafluoroethylene group (19 of 44, 43 percent). </p><p></p><p class="headingAnchor" id="H4177973754"><span class="h3">Revision using distal inflow</span><span class="headingEndMark"> — </span>In patients with HAIDI requiring flow reduction, the RUDI procedure  (<a class="graphic graphic_figure graphicRef76970" href="/d/graphic/76970.html" rel="external">figure 2</a>) has been an effective strategy. In this procedure, the AV fistula is ligated at its origin and a vein or prosthetic conduit is used to establish inflow from a more distal arterial source, usually proximal to mid radial artery. By using a smaller distal artery as inflow, resistance is added to the system and the AV fistula is lengthened with a small-diameter bypass. In small series, RUDI has been successful in reducing flow in high-flow AV fistulas and relieving symptoms of DASS [<a href="#rid58">58-61</a>]. </p><p class="headingAnchor" id="H3326146234"><span class="h3">Distal revascularization interval ligation</span><span class="headingEndMark"> — </span>Originally described in 1988, the DRIL procedure  (<a class="graphic graphic_figure graphicRef76970" href="/d/graphic/76970.html" rel="external">figure 2</a>) has been successful in reliably restoring antegrade flow to the ischemic limb by eliminating the potential physiologic pathway for DASS [<a href="#rid62">62</a>]. The procedure combines performance of a bypass from above the arterial anastomosis of the AV fistula to a distal vessel, and ligation of the artery distal to the original AV fistula anastomosis to prevent reversal of flow. The ligation and bypass procedures are performed at a single surgery [<a href="#rid63">63,64</a>]. </p><p>Several studies have confirmed both excellent bypass patency rates and the effectiveness of the DRIL procedure in relieving symptoms of DASS [<a href="#rid5">5,62,65-68</a>]. Although the DRIL procedure has proven efficacy in the treatment of steal, concerns remain about arterial ligation and reliance on the conduit used for distal revascularization [<a href="#rid68">68-70</a>]. There may be an understandable reluctance to ligate a normal artery, making alternative treatment options, such as PAI, attractive. (See <a class="local">'Proximalization of arterial inflow'</a> below.)</p><p class="headingAnchor" id="H3201649794"><span class="h3">Proximalization of arterial inflow</span><span class="headingEndMark"> — </span>The PAI procedure  (<a class="graphic graphic_figure graphicRef76970" href="/d/graphic/76970.html" rel="external">figure 2</a>) is intended to move the inflow for the AV access to a more proximal arterial level, specifically the axillary or proximal brachial artery [<a href="#rid71">71</a>]. Zanow, who originally described this technique, experimentally demonstrated the hemodynamic advantages and improvement in distal perfusion of a more centrally located AV anastomosis [<a href="#rid28">28</a>]. To perform PAI, a conduit of vein or polytetrafluoroethylene is used as an interposition graft from the axillary or proximal brachial artery to the AV fistula or AV graft above the previous brachial artery anastomosis, and the access is ligated at the previous anastomosis. </p><p>PAI has been effective in treating HAIDI without the need to perform arterial ligation, although caution is advised in using this procedure in the presence of extensive tissue loss where access ligation may be a better option  (<a class="graphic graphic_waveform graphicRef122926" href="/d/graphic/122926.html" rel="external">waveform 1</a>) [<a href="#rid72">72</a>].</p><p class="headingAnchor" id="H366185546"><span class="h2">Arteriovenous access ligation</span><span class="headingEndMark"> — </span>Although it is important to make every possible effort to preserve a functioning hemodialysis AV access, there are situations in which ligation of the AV access may be an appropriate choice. Severe functional impairment or impending or frank tissue necrosis that cannot be treated with preservation of the AV access mandates abandonment of the AV access. Severe complications in the immediate postoperative period (eg, bleeding, intractable steal) may also indicate AV access ligation. Any unused or unusable AV fistula that is causing steal should be carefully evaluated for ligation. IMN is also an indication for ligation of the AV access, acknowledging that improvement in symptoms is unpredictable. </p><p class="headingAnchor" id="H2887523366"><span class="h1">SOCIETY GUIDELINE LINKS</span><span class="headingEndMark"> — </span>Links to society and government-sponsored guidelines from selected countries and regions around the world are provided separately. (See  <a class="medical medical_society_guidelines" href="/d/html/112932.html" rel="external">"Society guideline links: Dialysis"</a> and  <a class="medical medical_society_guidelines" href="/d/html/132674.html" rel="external">"Society guideline links: Hemodialysis vascular access"</a> and  <a class="medical medical_society_guidelines" href="/d/html/118637.html" rel="external">"Society guideline links: Acute extremity ischemia"</a>.)</p><p class="headingAnchor" id="H670222257"><span class="h1">INFORMATION FOR PATIENTS</span><span class="headingEndMark"> — </span>UpToDate offers two types of patient education materials, "The Basics" and "Beyond the Basics." The Basics patient education pieces are written in plain language, at the 5<sup>th</sup> to 6<sup>th</sup> grade reading level, and they answer the four or five key questions a patient might have about a given condition. These articles are best for patients who want a general overview and who prefer short, easy-to-read materials. Beyond the Basics patient education pieces are longer, more sophisticated, and more detailed. These articles are written at the 10<sup>th</sup> to 12<sup>th</sup> grade reading level and are best for patients who want in-depth information and are comfortable with some medical jargon.</p><p>Here are the patient education articles that are relevant to this topic. We encourage you to print or e-mail these topics to your patients. (You can also locate patient education articles on a variety of subjects by searching on "patient info" and the keyword(s) of interest.)</p><p class="bulletIndent1"><span class="glyph">●</span>Basics topics (see  <a class="medical medical_basics" href="/d/html/15405.html" rel="external">"Patient education: Chronic kidney disease (The Basics)"</a> and  <a class="medical medical_basics" href="/d/html/16439.html" rel="external">"Patient education: Dialysis and diet (The Basics)"</a>)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Beyond the Basics topics (see  <a class="medical medical_patient" href="/d/html/4410.html" rel="external">"Patient education: Chronic kidney disease (Beyond the Basics)"</a> and  <a class="medical medical_patient" href="/d/html/4414.html" rel="external">"Patient education: Hemodialysis (Beyond the Basics)"</a>)</p><p></p><p class="headingAnchor" id="H1588040343"><span class="h1">SUMMARY AND RECOMMENDATIONS</span></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Ischemic complications</strong> – Hemodialysis access-induced distal ischemia (HAIDI) including dialysis access steal syndrome (DASS) and ischemic monomelic neuropathy (IMN) occur for a variety of reasons that almost always include decreased blood flow to the distal extremity resulting from increased blood flow through the AV access. The incidence and timing vary with the type and location of the AV access. (See <a class="local">'Introduction'</a> above and <a class="local">'Incidence, risk factors, and prevention'</a> above.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Risk factors</strong> – Identifying patients with risk factors is important so that preemptive measures to reduce the risk of ischemic complications can be implemented. Risk factors include brachial artery inflow, female sex, diabetes, atherosclerotic vascular disease (coronary heart disease, peripheral artery disease), and advanced age. (See <a class="local">'Risk factors'</a> above.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Risk reduction</strong> – Although it is not possible to predict for certain the development of ischemic complications in individual patients, steps can be taken to minimize the risk. These include preemptive identification of proximal arterial disease and avoiding the brachial artery as an inflow vessel and, if using the brachial artery cannot be avoided, limiting the length of the arteriotomy to reduce inflow. (See <a class="local">'Strategies for prevention'</a> above.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Clinical manifestations and diagnosis</strong></p><p></p><p class="bulletIndent2"><span class="glyph">•</span><strong>DASS</strong> – DASS presents with typical clinical features of upper extremity ischemia (hand pain, coolness, diminished sensory/motor function) and can occur in high- or low-volume-flow AV accesses. The diagnosis of DASS is predominantly clinical based on history and physical examination and by noting an improvement in the patient's symptoms with manual compression of the AV access. The diagnosis can be confirmed using noninvasive vascular testing. For patients in whom a proximal lesion is suspected, upper extremity arteriography is appropriate. (See <a class="local">'Diagnosis'</a> above.)</p><p></p><p class="bulletIndent2"><span class="glyph">•</span><strong>IMN</strong> – IMN is a very rare variant that presents with severe hand pain. Differentiating IMN from DASS is important to implement appropriate treatment to preserve hand function. (See <a class="local">'Clinical manifestations'</a> above and <a class="local">'Differentiating IMN from DASS'</a> above and <a class="local">'Arteriovenous access ligation for IMN'</a> above.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Staging of ischemia and management </strong>– Staging is generally based on the clinical presentation  (<a class="graphic graphic_table graphicRef123002" href="/d/graphic/123002.html" rel="external">table 1</a>) and correlates with the need for intervention. Surgical treatment should focus on preservation of a functional AV access while alleviating ischemic symptoms. Treatment options include AV access ligation for severe ischemia, banding procedures to reduce flow in the high-flow AV access, or procedures to improve distal blood flow in the low- or normal-flow AV access  (<a class="graphic graphic_algorithm graphicRef122924" href="/d/graphic/122924.html" rel="external">algorithm 1</a>). (See <a class="local">'Approach to management'</a> above and <a class="local">'Treatment options'</a> above and <a class="local">'Clinical staging'</a> above.)</p><p></p><p class="bulletIndent2"><span class="glyph">•</span><strong>Minimal ischemia</strong> – Patients with minimal ischemia (stage I and IIa) do not require intervention and should be managed conservatively with close observation of symptoms. (See <a class="local">'Individualized approach to HAIDI'</a> above.)</p><p></p><p class="bulletIndent2"><span class="glyph">•</span><strong>Reversible ischemia</strong> – Patients with intolerable but reversible ischemia (stage IIb, III, and IVa) require intervention, the nature of which is based on the volume flow rate of the AV access. Proximal artery inflow lesions should be addressed prior to interventions involving the AV access.(See <a class="local">'Quantifying arteriovenous access flow'</a> above and <a class="local">'Treatment of inflow stenosis'</a> above.)</p><p></p><p class="bulletIndent3"><span class="glyph">-</span>A high-flow AV access (&gt;1500 mL/min) may require only flow reduction, which is accomplished with precision banding (minimally invasive or open surgical techniques) in concert with duplex ultrasound assessment of AV access flow. Another option is the Revision Using Distal Inflow (RUDI) procedure. (See <a class="local">'Precision banding'</a> above and <a class="local">'Revision using distal inflow'</a> above.)</p><p></p><p class="bulletIndent3"><span class="glyph">-</span>A low- or normal-flow AV access (≤1500 mL/min) will require revascularization to increase distal perfusion to improve ischemia and maintain AV access function. Options include the distal revascularization interval ligation (DRIL) or proximalization of arterial inflow (PAI) procedures. Specifically for the wrist AV fistula, ligation of the distal radial artery alone may improve flow through the AV access. (See <a class="local">'Distal revascularization interval ligation'</a> above and <a class="local">'Distal artery occlusion'</a> above and <a class="local">'Proximalization of arterial inflow'</a> above.)</p><p></p><p class="bulletIndent2"><span class="glyph">•</span><strong>Irreversible ischemia</strong> – Patients with extensive tissue loss and significant functional deficits have irreversible ischemia (Stage IVb). The limb is managed expectantly; amputation is frequently necessary. (See  <a class="medical medical_review" href="/d/html/15224.html" rel="external">"Upper extremity amputation"</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Management of IMN</strong> – For IMN, we agree with guidelines that recommend immediate AV access closure. Unfortunately, even with timely ligation of the AV access, most patients with IMN demonstrate only partial clinical recovery. (See <a class="local">'Arteriovenous access ligation for IMN'</a> above.)</p></div><div class="headingAnchor" id="references"><ol id="reference"><li><a class="nounderline abstract_t">Thermann F. Intervention for access-induced ischemia: which option is the best? J Vasc Access 2015; 16 Suppl 9:S102.</a></li><li><a class="nounderline abstract_t">Padberg FT Jr, Calligaro KD, Sidawy AN. Complications of arteriovenous hemodialysis access: recognition and management. J Vasc Surg 2008; 48:55S.</a></li><li><a class="nounderline abstract_t">Morsy AH, Kulbaski M, Chen C, et al. Incidence and characteristics of patients with hand ischemia after a hemodialysis access procedure. J Surg Res 1998; 74:8.</a></li><li><a class="nounderline abstract_t">Davidson D, Louridas G, Guzman R, et al. Steal syndrome complicating upper extremity hemoaccess procedures: incidence and risk factors. Can J Surg 2003; 46:408.</a></li><li><a class="nounderline abstract_t">Kordzadeh A, Parsa AD. A systematic review of distal revascularization and interval ligation for the treatment of vascular access-induced ischemia. J Vasc Surg 2019; 70:1364.</a></li><li class="breakAll">Zanow J, Petzold M, Petzold K, et al. Diagnosis and differentiated treatment of ischemia in patients with arteriovenous vascular access. In: Vascular Access for Hemodialysis VII, Henry ML (Ed), Gore, Chicago 2001. p.201.</li><li><a class="nounderline abstract_t">Huber TS, Larive B, Imrey PB, et al. Access-related hand ischemia and the Hemodialysis Fistula Maturation Study. J Vasc Surg 2016; 64:1050.</a></li><li><a class="nounderline abstract_t">Rocha A, Silva F, Queirós J, et al. Predictors of steal syndrome in hemodialysis patients. Hemodial Int 2012; 16:539.</a></li><li><a class="nounderline abstract_t">Gupta N, Yuo TH, Konig G 4th, et al. Treatment strategies of arterial steal after arteriovenous access. J Vasc Surg 2011; 54:162.</a></li><li><a class="nounderline abstract_t">Goff CD, Sato DT, Bloch PH, et al. Steal syndrome complicating hemodialysis access procedures: can it be predicted? Ann Vasc Surg 2000; 14:138.</a></li><li><a class="nounderline abstract_t">Valentine RJ, Bouch CW, Scott DJ, et al. Do preoperative finger pressures predict early arterial steal in hemodialysis access patients? A prospective analysis. J Vasc Surg 2002; 36:351.</a></li><li><a class="nounderline abstract_t">Yeager RA, Moneta GL, Edwards JM, et al. Relationship of hemodialysis access to finger gangrene in patients with end-stage renal disease. J Vasc Surg 2002; 36:245.</a></li><li><a class="nounderline abstract_t">Kokkosis AA, Abramowitz SD, Schwitzer J, et al. Inflow stenosis as a contributing factor in the etiology of AV access-induced ischemic steal. J Vasc Access 2014; 15:286.</a></li><li><a class="nounderline abstract_t">Jennings WC, Brown RE, Ruiz C. Primary arteriovenous fistula inflow proximalization for patients at high risk for dialysis access-associated ischemic steal syndrome. J Vasc Surg 2011; 54:554.</a></li><li><a class="nounderline abstract_t">Jennings WC, Mallios A, Mushtaq N. Proximal radial artery arteriovenous fistula for hemodialysis vascular access. J Vasc Surg 2018; 67:244.</a></li><li><a class="nounderline abstract_t">Jennings W, Brown R, Blebea J, et al. Prevention of vascular access hand ischemia using the axillary artery as inflow. J Vasc Surg 2013; 58:1305.</a></li><li><a class="nounderline abstract_t">Sidawy AN, Spergel LM, Besarab A, et al. The Society for Vascular Surgery: clinical practice guidelines for the surgical placement and maintenance of arteriovenous hemodialysis access. J Vasc Surg 2008; 48:2S.</a></li><li><a class="nounderline abstract_t">Bashar K, Medani M, Bashar H, et al. End-To-Side versus Side-To-Side Anastomosis in Upper Limb Arteriovenous Fistula for Dialysis Access: A Systematic Review and a Meta-Analysis. Ann Vasc Surg 2018; 47:43.</a></li><li><a class="nounderline abstract_t">Dammers R, Planken RN, Pouls KP, et al. Evaluation of 4-mm to 7-mm versus 6-mm prosthetic brachial-antecubital forearm loop access for hemodialysis: results of a randomized multicenter clinical trial. J Vasc Surg 2003; 37:143.</a></li><li><a class="nounderline abstract_t">Polo JR, Ligero JM, Diaz-Cartelle J, et al. Randomized comparison of 6-mm straight grafts versus 6- to 8-mm tapered grafts for brachial-axillary dialysis access. J Vasc Surg 2004; 40:319.</a></li><li><a class="nounderline abstract_t">Roberts L, Farber A, Jones DW, et al. Tapered arteriovenous grafts do not provide significant advantage over nontapered grafts in upper extremity dialysis access. J Vasc Surg 2019; 69:1552.</a></li><li><a class="nounderline abstract_t">Moini M, Williams GM, Pourabbasi MS, et al. Side-to-side arteriovenous fistula at the elbow with perforating vein ligation. J Vasc Surg 2008; 47:1274.</a></li><li><a class="nounderline abstract_t">Vaes RH, Wouda R, Teijink JA, Scheltinga MR. Venous Side Branch Ligation as a First Step Treatment for Haemodialysis Access Induced Hand Ischaemia: Effects on Access Flow Volume and Digital Perfusion. Eur J Vasc Endovasc Surg 2015; 50:810.</a></li><li><a class="nounderline abstract_t">Lok CE, Huber TS, Lee T, et al. KDOQI Clinical Practice Guideline for Vascular Access: 2019 Update. Am J Kidney Dis 2020; 75:S1.</a></li><li><a class="nounderline abstract_t">Miles AM. Vascular steal syndrome and ischaemic monomelic neuropathy: two variants of upper limb ischaemia after haemodialysis vascular access surgery. Nephrol Dial Transplant 1999; 14:297.</a></li><li><a class="nounderline abstract_t">Scheltinga MR, van Hoek F, Bruijninckx CM. Time of onset in haemodialysis access-induced distal ischaemia (HAIDI) is related to the access type. Nephrol Dial Transplant 2009; 24:3198.</a></li><li><a class="nounderline abstract_t">Thermann F, Kornhuber M. Ischemic monomelic neuropathy: a rare but important complication after hemodialysis access placement--a review. J Vasc Access 2011; 12:113.</a></li><li><a class="nounderline abstract_t">Zanow J, Krueger U, Reddemann P, Scholz H. Experimental study of hemodynamics in procedures to treat access-related ischemia. J Vasc Surg 2008; 48:1559.</a></li><li><a class="nounderline abstract_t">Beathard GA, Spergel LM. Hand ischemia associated with dialysis vascular access: an individualized access flow-based approach to therapy. Semin Dial 2013; 26:287.</a></li><li><a class="nounderline abstract_t">Sidawy AN, Gray R, Besarab A, et al. Recommended standards for reports dealing with arteriovenous hemodialysis accesses. J Vasc Surg 2002; 35:603.</a></li><li><a class="nounderline abstract_t">Asif A, Leon C, Merrill D, et al. Arterial steal syndrome: a modest proposal for an old paradigm. Am J Kidney Dis 2006; 48:88.</a></li><li><a class="nounderline abstract_t">Yilmaz C, Ozcan K, Erkan N. Dialysis access-associated steal syndrome presenting as bidirectional flow at duplex Doppler ultrasound. AJR Am J Roentgenol 2009; 193:W568.</a></li><li><a class="nounderline abstract_t">Moghazy KM. Value of color Doppler sonography in the assessment of hemodialysis access dysfunction. Saudi J Kidney Dis Transpl 2009; 20:35.</a></li><li><a class="nounderline abstract_t">Malik J, Slavikova M, Maskova J. Dialysis access-associated steal syndrome: the role of ultrasonography. J Nephrol 2003; 16:903.</a></li><li class="breakAll">Scher LA, Shah AR. Vascular access neuropathic syndrome: Ischemic monomelic neuropathy. In: Vascular Access: Principles and Practice, 5th ed, Wilson SE (Ed), Lippincott Williams &amp; Wilkins, Philadelphia 2009. p.182.</li><li><a class="nounderline abstract_t">Schanzer A, Nguyen LL, Owens CD, Schanzer H. Use of digital pressure measurements for the diagnosis of AV access-induced hand ischemia. Vasc Med 2006; 11:227.</a></li><li><a class="nounderline abstract_t">Bavare CS, Bismuth J, El-Sayed HF, et al. Volume Flow Measurements in Arteriovenous Dialysis Access in Patients with and without Steal Syndrome. Int J Vasc Med 2013; 2013:328601.</a></li><li><a class="nounderline abstract_t">Miller GA, Hwang WW. Challenges and management of high-flow arteriovenous fistulae. Semin Nephrol 2012; 32:545.</a></li><li><a class="nounderline abstract_t">Mickley V. Steal syndrome--strategies to preserve vascular access and extremity. Nephrol Dial Transplant 2008; 23:19.</a></li><li><a class="nounderline abstract_t">Ramdon A, Breyre A, Kalapatapu V. A Case of Acute Ischemic Monomelic Neuropathy and Review of the Literature. Ann Vasc Surg 2017; 42:301.e1.</a></li><li><a class="nounderline abstract_t">Jennings WC, Miller GA, Coburn MZ, et al. Vascular access flow reduction for arteriovenous fistula salvage in symptomatic patients with central venous occlusion. J Vasc Access 2012; 13:157.</a></li><li><a class="nounderline abstract_t">Wasse H, Singapuri MS. High-output heart failure: how to define it, when to treat it, and how to treat it. Semin Nephrol 2012; 32:551.</a></li><li><a class="nounderline abstract_t">Hicks CW, Bae S, Pozo ME, et al. Practice patterns in arteriovenous fistula ligation among kidney transplant recipients in the United States Renal Data Systems. J Vasc Surg 2019; 70:842.</a></li><li><a class="nounderline abstract_t">Miller GA, Goel N, Friedman A, et al. The MILLER banding procedure is an effective method for treating dialysis-associated steal syndrome. Kidney Int 2010; 77:359.</a></li><li><a class="nounderline abstract_t">Bourquelot P. Access flow reduction for cardiac failure. J Vasc Access 2016; 17 Suppl 1:S60.</a></li><li><a class="nounderline abstract_t">Gradman WS, Pozrikidis C. Analysis of options for mitigating hemodialysis access-related ischemic steal phenomena. Ann Vasc Surg 2004; 18:59.</a></li><li><a class="nounderline abstract_t">Cheun TJ, Jayakumar L, Sideman MJ, et al. Upper extremity arterial endovascular interventions for symptomatic vascular access-induced steal syndrome. J Vasc Surg 2019; 70:1896.</a></li><li><a class="nounderline abstract_t">Alabi O, Teruya T, Sheng N, et al. Distal Radial Artery Embolization: An Alternative Approach towards Access Preservation and Limb Salvage in Radiocephalic Arteriovenous Fistulae Complicated by Steal Syndrome. Ann Vasc Surg 2016; 33:131.e1.</a></li><li><a class="nounderline abstract_t">Gkotsis G, Jennings WC, Malik J, et al. Treatment of High Flow Arteriovenous Fistulas after Successful Renal Transplant Using a Simple Precision Banding Technique. Ann Vasc Surg 2016; 31:85.</a></li><li><a class="nounderline abstract_t">Wang S, Asif A, Jennings WC. Dilator-assisted banding and beyond: proposing an algorithm for managing dialysis access-associated steal syndrome. J Vasc Access 2016; 17:299.</a></li><li><a class="nounderline abstract_t">Goel N, Miller GA, Jotwani MC, et al. Minimally Invasive Limited Ligation Endoluminal-assisted Revision (MILLER) for treatment of dialysis access-associated steal syndrome. Kidney Int 2006; 70:765.</a></li><li><a class="nounderline abstract_t">Shemesh D, Goldin I, Olsha O. Banding between dialysis puncture sites to treat severe ischemic steal syndrome in low flow autogenous arteriovenous access. J Vasc Surg 2010; 52:495.</a></li><li><a class="nounderline abstract_t">Png CYM, Beckerman WE, Faries PL, Finlay DJ. Endovascular Treatment of Dialysis Access-Induced Hand Ischemia Using a Flared Stent-Graft. J Endovasc Ther 2017; 24:743.</a></li><li><a class="nounderline abstract_t">Ascher E, Mandel JE, Marks NA, Hingorani AP. A new endovascular technique for the treatment of dialysis-associated steal syndrome. Vascular 2018; 26:335.</a></li><li><a class="nounderline abstract_t">Rivers SP, Scher LA, Veith FJ. Correction of steal syndrome secondary to hemodialysis access fistulas: a simplified quantitative technique. Surgery 1992; 112:593.</a></li><li><a class="nounderline abstract_t">Vaes RH, Wouda R, van Loon M, et al. Effectiveness of surgical banding for high flow in brachial artery-based hemodialysis vascular access. J Vasc Surg 2015; 61:762.</a></li><li><a class="nounderline abstract_t">Gerrickens MWM, Vaes RHD, Wiersma V, et al. Revision using distal inflow for high flow hemodialysis access alters arterial flow characteristics in the dialysis arm. J Vasc Surg 2020; 71:920.</a></li><li><a class="nounderline abstract_t">Misskey J, Yang C, MacDonald S, et al. A comparison of revision using distal inflow and distal revascularization-interval ligation for the management of severe access-related hand ischemia. J Vasc Surg 2016; 63:1574.</a></li><li><a class="nounderline abstract_t">Minion DJ, Moore E, Endean E. Revision using distal inflow: a novel approach to dialysis-associated steal syndrome. Ann Vasc Surg 2005; 19:625.</a></li><li><a class="nounderline abstract_t">Loh TM, Bennett ME, Peden EK. Revision using distal inflow is a safe and effective treatment for ischemic steal syndrome and pathologic high flow after access creation. J Vasc Surg 2016; 63:441.</a></li><li><a class="nounderline abstract_t">Vaes RH, van Loon M, Vaes SM, et al. One-year efficacy of the RUDI technique for flow reduction in high-flow autologous brachial artery-based hemodialysis vascular access. J Vasc Access 2015; 16 Suppl 9:S96.</a></li><li><a class="nounderline abstract_t">Schanzer H, Schwartz M, Harrington E, Haimov M. Treatment of ischemia due to "steal" by arteriovenous fistula with distal artery ligation and revascularization. J Vasc Surg 1988; 7:770.</a></li><li><a class="nounderline abstract_t">Wixon CL, Hughes JD, Mills JL. Understanding strategies for the treatment of ischemic steal syndrome after hemodialysis access. J Am Coll Surg 2000; 191:301.</a></li><li><a class="nounderline abstract_t">Berman SS, Gentile AT, Glickman MH, et al. Distal revascularization-interval ligation for limb salvage and maintenance of dialysis access in ischemic steal syndrome. J Vasc Surg 1997; 26:393.</a></li><li><a class="nounderline abstract_t">Knox RC, Berman SS, Hughes JD, et al. Distal revascularization-interval ligation: a durable and effective treatment for ischemic steal syndrome after hemodialysis access. J Vasc Surg 2002; 36:250.</a></li><li><a class="nounderline abstract_t">Aimaq R, Katz SG. Using distal revascularization with interval ligation as the primary treatment of hand ischemia after dialysis access creation. J Vasc Surg 2013; 57:1073.</a></li><li><a class="nounderline abstract_t">Schanzer H, Eisenberg D. Management of steal syndrome resulting from dialysis access. Semin Vasc Surg 2004; 17:45.</a></li><li><a class="nounderline abstract_t">Scali ST, Chang CK, Raghinaru D, et al. Prediction of graft patency and mortality after distal revascularization and interval ligation for hemodialysis access-related hand ischemia. J Vasc Surg 2013; 57:451.</a></li><li><a class="nounderline abstract_t">Davidson I, Beathard G, Gallieni M, Ross J. The DRIL procedure for arteriovenous access ischemic steal: a controversial approach. J Vasc Access 2017; 18:1.</a></li><li><a class="nounderline abstract_t">Anaya-Ayala JE, Pettigrew CD, Ismail N, et al. Management of dialysis access-associated "steal" syndrome with DRIL procedure: challenges and clinical outcomes. J Vasc Access 2012; 13:299.</a></li><li><a class="nounderline abstract_t">Zanow J, Kruger U, Scholz H. Proximalization of the arterial inflow: a new technique to treat access-related ischemia. J Vasc Surg 2006; 43:1216.</a></li><li><a class="nounderline abstract_t">Thermann F, Wollert U, Ukkat J, Dralle H. Proximalization of the arterial inflow (PAI) in patients with dialysis access-induced ischemic syndrome: first report on long-term clinical results. J Vasc Access 2010; 11:143.</a></li></ol></div><div id="topicVersionRevision">Topic 113760 Version 17.0</div></div>
<div class="row">
<div class="col-12">
<h4 style="text-align: center;padding: 20px;color: cadetblue;">References</h4>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/25751562" id="rid0" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>1 : Intervention for access-induced ischemia: which option is the best?</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/19000594" id="rid1" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>2 : Complications of arteriovenous hemodialysis access: recognition and management.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/9536965" id="rid2" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>3 : Incidence and characteristics of patients with hand ischemia after a hemodialysis access procedure.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/14680346" id="rid3" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>4 : Steal syndrome complicating upper extremity hemoaccess procedures: incidence and risk factors.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/31153703" id="rid4" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>5 : A systematic review of distal revascularization and interval ligation for the treatment of vascular access-induced ischemia.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/31153703" id="rid5" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>6 : A systematic review of distal revascularization and interval ligation for the treatment of vascular access-induced ischemia.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/27478007" id="rid6" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>7 : Access-related hand ischemia and the Hemodialysis Fistula Maturation Study.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/22510166" id="rid7" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>8 : Predictors of steal syndrome in hemodialysis patients.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/21276691" id="rid8" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>9 : Treatment strategies of arterial steal after arteriovenous access.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/10742428" id="rid9" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>10 : Steal syndrome complicating hemodialysis access procedures: can it be predicted?</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/12170218" id="rid10" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>11 : Do preoperative finger pressures predict early arterial steal in hemodialysis access patients? A prospective analysis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/12170204" id="rid11" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>12 : Relationship of hemodialysis access to finger gangrene in patients with end-stage renal disease.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/24474518" id="rid12" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>13 : Inflow stenosis as a contributing factor in the etiology of AV access-induced ischemic steal.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/21458197" id="rid13" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>14 : Primary arteriovenous fistula inflow proximalization for patients at high risk for dialysis access-associated ischemic steal syndrome.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/28912005" id="rid14" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>15 : Proximal radial artery arteriovenous fistula for hemodialysis vascular access.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/23810298" id="rid15" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>16 : Prevention of vascular access hand ischemia using the axillary artery as inflow.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/19000589" id="rid16" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>17 : The Society for Vascular Surgery: clinical practice guidelines for the surgical placement and maintenance of arteriovenous hemodialysis access.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/28916306" id="rid17" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>18 : End-To-Side versus Side-To-Side Anastomosis in Upper Limb Arteriovenous Fistula for Dialysis Access: A Systematic Review and a Meta-Analysis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/12514592" id="rid18" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>19 : Evaluation of 4-mm to 7-mm versus 6-mm prosthetic brachial-antecubital forearm loop access for hemodialysis: results of a randomized multicenter clinical trial.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/15297828" id="rid19" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>20 : Randomized comparison of 6-mm straight grafts versus 6- to 8-mm tapered grafts for brachial-axillary dialysis access.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/30583896" id="rid20" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>21 : Tapered arteriovenous grafts do not provide significant advantage over nontapered grafts in upper extremity dialysis access.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/18467069" id="rid21" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>22 : Side-to-side arteriovenous fistula at the elbow with perforating vein ligation.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/26391963" id="rid22" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>23 : Venous Side Branch Ligation as a First Step Treatment for Haemodialysis Access Induced Hand Ischaemia: Effects on Access Flow Volume and Digital Perfusion.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/32778223" id="rid23" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>24 : KDOQI Clinical Practice Guideline for Vascular Access: 2019 Update.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/10069179" id="rid24" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>25 : Vascular steal syndrome and ischaemic monomelic neuropathy: two variants of upper limb ischaemia after haemodialysis vascular access surgery.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/19403932" id="rid25" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>26 : Time of onset in haemodialysis access-induced distal ischaemia (HAIDI) is related to the access type.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/21360465" id="rid26" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>27 : Ischemic monomelic neuropathy: a rare but important complication after hemodialysis access placement--a review.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/18771888" id="rid27" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>28 : Experimental study of hemodynamics in procedures to treat access-related ischemia.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/23581731" id="rid28" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>29 : Hand ischemia associated with dialysis vascular access: an individualized access flow-based approach to therapy.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/11877717" id="rid29" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>30 : Recommended standards for reports dealing with arteriovenous hemodialysis accesses.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/16797390" id="rid30" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>31 : Arterial steal syndrome: a modest proposal for an old paradigm.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/19933633" id="rid31" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>32 : Dialysis access-associated steal syndrome presenting as bidirectional flow at duplex Doppler ultrasound.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/19112217" id="rid32" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>33 : Value of color Doppler sonography in the assessment of hemodialysis access dysfunction.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/14736019" id="rid33" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>34 : Dialysis access-associated steal syndrome: the role of ultrasonography.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/14736019" id="rid34" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>35 : Dialysis access-associated steal syndrome: the role of ultrasonography.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/17390545" id="rid35" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>36 : Use of digital pressure measurements for the diagnosis of AV access-induced hand ischemia.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/24066232" id="rid36" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>37 : Volume Flow Measurements in Arteriovenous Dialysis Access in Patients with and without Steal Syndrome.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/23217334" id="rid37" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>38 : Challenges and management of high-flow arteriovenous fistulae.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/17905806" id="rid38" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>39 : Steal syndrome--strategies to preserve vascular access and extremity.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/28341506" id="rid39" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>40 : A Case of Acute Ischemic Monomelic Neuropathy and Review of the Literature.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/21983828" id="rid40" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>41 : Vascular access flow reduction for arteriovenous fistula salvage in symptomatic patients with central venous occlusion.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/23217335" id="rid41" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>42 : High-output heart failure: how to define it, when to treat it, and how to treat it.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/30853386" id="rid42" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>43 : Practice patterns in arteriovenous fistula ligation among kidney transplant recipients in the United States Renal Data Systems.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/20010547" id="rid43" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>44 : The MILLER banding procedure is an effective method for treating dialysis-associated steal syndrome.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/26951907" id="rid44" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>45 : Access flow reduction for cardiac failure.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/14712381" id="rid45" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>46 : Analysis of options for mitigating hemodialysis access-related ischemic steal phenomena.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/31126767" id="rid46" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>47 : Upper extremity arterial endovascular interventions for symptomatic vascular access-induced steal syndrome.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/26965823" id="rid47" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>48 : Distal Radial Artery Embolization: An Alternative Approach towards Access Preservation and Limb Salvage in Radiocephalic Arteriovenous Fistulae Complicated by Steal Syndrome.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/26616507" id="rid48" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>49 : Treatment of High Flow Arteriovenous Fistulas after Successful Renal Transplant Using a Simple Precision Banding Technique.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/27312765" id="rid49" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>50 : Dilator-assisted banding and beyond: proposing an algorithm for managing dialysis access-associated steal syndrome.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/16816841" id="rid50" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>51 : Minimally Invasive Limited Ligation Endoluminal-assisted Revision (MILLER) for treatment of dialysis access-associated steal syndrome.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/20385463" id="rid51" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>52 : Banding between dialysis puncture sites to treat severe ischemic steal syndrome in low flow autogenous arteriovenous access.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/28675950" id="rid52" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>53 : Endovascular Treatment of Dialysis Access-Induced Hand Ischemia Using a Flared Stent-Graft.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/29117811" id="rid53" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>54 : A new endovascular technique for the treatment of dialysis-associated steal syndrome.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/1519174" id="rid54" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>55 : Correction of steal syndrome secondary to hemodialysis access fistulas: a simplified quantitative technique.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/25446282" id="rid55" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>56 : Effectiveness of surgical banding for high flow in brachial artery-based hemodialysis vascular access.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/31619349" id="rid56" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>57 : Revision using distal inflow for high flow hemodialysis access alters arterial flow characteristics in the dialysis arm.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/26776897" id="rid57" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>58 : A comparison of revision using distal inflow and distal revascularization-interval ligation for the management of severe access-related hand ischemia.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/16052391" id="rid58" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>59 : Revision using distal inflow: a novel approach to dialysis-associated steal syndrome.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/26492999" id="rid59" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>60 : Revision using distal inflow is a safe and effective treatment for ischemic steal syndrome and pathologic high flow after access creation.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/25751561" id="rid60" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>61 : One-year efficacy of the RUDI technique for flow reduction in high-flow autologous brachial artery-based hemodialysis vascular access.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/3373618" id="rid61" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>62 : Treatment of ischemia due to "steal" by arteriovenous fistula with distal artery ligation and revascularization.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/10989904" id="rid62" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>63 : Understanding strategies for the treatment of ischemic steal syndrome after hemodialysis access.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/9308585" id="rid63" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>64 : Distal revascularization-interval ligation for limb salvage and maintenance of dialysis access in ischemic steal syndrome.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/12170205" id="rid64" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>65 : Distal revascularization-interval ligation: a durable and effective treatment for ischemic steal syndrome after hemodialysis access.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/23375137" id="rid65" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>66 : Using distal revascularization with interval ligation as the primary treatment of hand ischemia after dialysis access creation.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/15011179" id="rid66" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>67 : Management of steal syndrome resulting from dialysis access.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/23244784" id="rid67" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>68 : Prediction of graft patency and mortality after distal revascularization and interval ligation for hemodialysis access-related hand ischemia.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/27739574" id="rid68" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>69 : The DRIL procedure for arteriovenous access ischemic steal: a controversial approach.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/22266588" id="rid69" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>70 : Management of dialysis access-associated "steal" syndrome with DRIL procedure: challenges and clinical outcomes.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/16765242" id="rid70" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>71 : Proximalization of the arterial inflow: a new technique to treat access-related ischemia.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/20155715" id="rid71" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>72 : Proximalization of the arterial inflow (PAI) in patients with dialysis access-induced ischemic syndrome: first report on long-term clinical results.</p>
</a>
</div>
</div>
</div>
</div>

</section>

</section>
<!-- End Main Menu Area -->
<!-- Start Search Popup Area -->


<!-- End Footer Area -->
<!-- Back to top -->

<a class="scrolltop" href="#top"><i class="icofont-hand-drawn-up"></i></a>
<!-- End Back to top -->
<!-- jQuery Min JS -->

<!-- Prpper JS -->

<!-- Bootstrap Min JS -->

<!-- Classy Nav Min Js -->

<!-- Owl Carousel Min Js -->

<!-- Magnific Popup JS -->

<!-- CounterUp JS -->

<!-- Waypoints JS -->

<!-- Form Validator Min JS -->

<!-- Contact Form Min JS -->

<!-- Main JS -->

<!-- Global site tag (gtag.js) - Google Analytics -->






</body>
</html>
